China Medical System Holdings Limited (CHSYF)
OTCMKTS
· Delayed Price · Currency is USD
0.931
0.00 (0.00%)
Mar 11, 2025, 4:00 PM EST
CHSYF Revenue
China Medical System Holdings had revenue of 3.61B CNY in the half year ending June 30, 2024, a decrease of -18.81%. This brings the company's revenue in the last twelve months to 7.01B, down -24.68% year-over-year. In the year 2023, China Medical System Holdings had annual revenue of 8.01B, down -12.43%.
Revenue (ttm)
7.01B CNY
Revenue Growth
-24.68%
P/S Ratio
n/a
Revenue / Employee
1.23M CNY
Employees
5,701
Market Cap
2.62B USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8.01B | -1.14B | -12.43% |
Dec 31, 2022 | 9.15B | 813.13M | 9.75% |
Dec 31, 2021 | 8.34B | 1.39B | 20.03% |
Dec 31, 2020 | 6.95B | 872.34M | 14.36% |
Dec 31, 2019 | 6.07B | 640.18M | 11.78% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
SS Innovations International | 16.04M |
Veradigm | 1.53B |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
Silence Therapeutics | 43.26M |
BioStem Technologies | 210.49M |